• Home>
  • Stocks>
  • Caplin Point Laboratories Ltd Share Price
Caplin Point Laboratories Ltd share price logo

Caplin Point Laboratories Ltd Share Price

(CAPLIPOINT)

₹1845.65▲1.97%

as on 04:01PM, 05 Mar 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Caplin Point Laboratories Ltd Performance

  • Day's Low

    Day's High

    ₹1,789.35
    Day's Price Range
    ₹1,867

  • 52 Week's Low

    52 Week's High

    ₹1,225
    52-Week Price Range
    ₹2,641
1 Month Return-17.69 %
3 Month Return-23.97 %
1 Year Return+ 26.56 %
Previous Close₹1,809.95
Open₹1,800.00
Volume1.02L
Upper Circuit-
Lower Circuit-
Market Cap₹13,757.74Cr

Caplin Point Laboratories Ltd Key Statistics

P/E Ratio

26.68

PEG Ratio

2.62

Market Cap

₹13,757.74 Cr

P/B Ratio

7.2

EPS

60.75

Dividend Yield

0.38

Sector

Pharmaceuticals

ROE

22.43

Caplin Point Laboratories Ltd Analyst Rating

based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts offering long term price targets for Caplin Point Laboratories Ltd. An average target of ₹2470

Source: S&P Global Market Intelligence

Caplin Point Laboratories Ltd Share analysis

Caplin Point Laboratories Ltd price forecast by 3 analysts

Upside of36.47%

High

₹2510

Target

₹2470.00

Low

₹2400

Caplin Point Laboratories Ltd target price ₹2470, a slight upside of 36.47% compared to current price of ₹1845.65. According to 3 analysts rating.

Source: S&P Global Market Intelligence

Key events for Caplin Point Laboratories Ltd

  • Caplin Steriles Secures USFDA Approval and Revenue Growth - 27 Feb, 2025

    Caplin Steriles, a subsidiary of Caplin Point Laboratories, received USFDA approval for its ophthalmic solution. The company reported significant revenue growth and increased FII stake to 4.86%.

  • Caplin Steriles Secures USFDA Approval for Eye Drops - 26 Feb, 2025

    Caplin Point Laboratories' subsidiary, Caplin Steriles, has received final USFDA approval for its generic ophthalmic solution, indicating strong market potential with $242 million in US sales.

  • Caplin Point Projects Strong Revenue Growth Ahead - 11 Feb, 2025

    Caplin Point Laboratories anticipates 13-14% revenue growth in FY26, driven by US expansion and a growing oncology segment. Q3FY25 results show a 13.6% YoY revenue increase, with EBITDA margins improving to 32.93%. The company's market cap is approximately ₹16,072.67 crore, with shares up nearly 43% over the past year.

  • Caplin Point Reports Strong Q3 FY25 Financials - 07 Feb, 2025

    Caplin Point Laboratories announced solid Q3 FY25 results, with revenue up 13.2% YoY to ₹493 crore and net profit increasing 17% YoY to ₹140.07 crore, driven by operational efficiencies and market demand.

  • Caplin Point Labs Gains USFDA Approval for Injection - 05 Feb, 2025

    Caplin Point Laboratories' subsidiary, Caplin Steriles Ltd, secured USFDA approval for Procainamide Hydrochloride Injection, leading to a 6% stock increase. The company reported significant revenue and profit growth in Q2FY25.

Insights on Caplin Point Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 1.62% to 1.86% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CAPLIPOINT has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, CAPLIPOINT stock has moved up by 26.6%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 18 quarters, 269.88 Cr → 524.32 Cr (in ₹), with an average increase of 3.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 13 quarters, 74.95 Cr → 138.96 Cr (in ₹), with an average increase of 5.0% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 3.70% to 4.86% in Dec 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.56% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 58.4% return, outperforming this stock by 31.8%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 23.90% to 22.47% in Dec 2024 quarter

Caplin Point Laboratories Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹435.50Cr (-)₹453.22Cr (↑4.07%)₹458.96Cr (↑1.27%)₹483.10Cr (↑5.26%)₹492.96Cr (↑2.04%)
Net Income₹119.82Cr (-)₹121.23Cr (↑1.18%)₹124.92Cr (↑3.04%)₹130.81Cr (↑4.72%)₹140.07Cr (↑7.08%)
Net Profit Margin27.51% (-)26.75% (↓2.76%)27.22% (↑1.76%)27.08% (↓0.51%)28.41% (↑4.91%)
Value in ₹ crore
Details2021202220232024
Total Assets₹860.99Cr (-)₹1,054.16Cr (↑22.44%)₹1,303.18Cr (↑23.62%)₹1,522.31Cr (↑16.82%)
Total Liabilities₹102.32Cr (-)₹123.51Cr (↑20.71%)₹163.27Cr (↑32.19%)₹132.16Cr (↓19.05%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹87.01Cr (-)₹294.64Cr (↑238.63%)₹230.97Cr (↓21.61%)₹157.10Cr (↓31.98%)₹111.01Cr (↓29.34%)

Index Inclusions

Nifty MidSmallcap 400

₹16,815.85

2.53 (▲414.6%)

Nifty Smallcap 250

₹14,291.05

2.71 (▲376.95%)

S&P BSE 250 SmallCap

₹5,739.66

2.63 (▲146.82%)

Nifty 500

₹20,256.50

1.7 (▲338.65%)

BSE Small-Cap

₹44,538.20

2.8 (▲1212.32%)

BSE 500

₹31,906.57

1.71 (▲536.92%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

S&P BSE 400 MidSmallCap

₹10,278.05

2.59 (▲259.58%)

BSE Healthcare

₹39,245.58

1.73 (▲666.06%)

Caplin Point Laboratories Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
70.56%
0.00
Foreign Institutions
4.86%
31.42
Mutual Funds
1.86%
14.58
Retail Investors
22.47%
-5.99
Others
0.25%
15.46

Caplin Point Laboratories Ltd Key Indicators

Details20202021202220232024
Return On Equity %38.32322.2422.6322.43
Details20202021202220232024
Return On Assets %31.128.1428.4428.8730.03
Details20202021202220232024
Book Value Per Share (₹)96.68128.12167.2219.22276.38
Details20202021202220232024
Earning Per Share (₹)28.4333.2440.6949.6760.75

Caplin Point Laboratories Ltd Valuation

Caplin Point Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (6.76x)

March 24, 2020

Today (26.68x)

March 4, 2025

Industry (49.34x)

March 4, 2025

Highest (40.01x)

December 27, 2024

LowHigh

Caplin Point Laboratories Ltd Earnings and Dividends

  • Caplin Point Laboratories Ltd Earnings Results

    Caplin Point Laboratories Ltd’s net profit jumped 18.57% since last year same period to ₹138.96Cr in the Q3 2024-2025. On a quarterly growth basis, Caplin Point Laboratories Ltd has generated 6.24% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Caplin Point Laboratories Ltd Dividends August,2024

    In the quarter ending June 2024, Caplin Point Laboratories Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.41%.

    Read More about Dividends

Caplin Point Laboratories Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Caplin Point Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.

More on Technical Analysis

Caplin Point Laboratories Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Caplin Point Laboratories Ltd
Caplin Point Laboratories Ltd
BUY₹13,757.74 Cr100.44%0.50₹461 Cr₹1,694 Cr
Suven Pharmaceuticals Ltd
Suven Pharmaceuticals Ltd
BUY₹29,621.18 Cr118.09%0.52₹300 Cr₹1,051 Cr
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd
BUY₹14,658.79 Cr22.64%0.57₹72 Cr₹6,702 Cr
Sun Pharma Advanced Research Company Ltd
Sun Pharma Advanced Research Company Ltd
NA₹4,122.72 Cr-3.67%0.79-₹388 Cr₹75 Cr
Rainbow Childrens Medicare Ltd
Rainbow Childrens Medicare Ltd
BUY₹13,067.67 Cr37.17%0.68₹218 Cr₹1,296 Cr
See all

About Caplin Point Laboratories Ltd

Caplin Point Laboratories Limited was founded in the year 1990 and is a fully integrated transnational pharmaceutical company. With over 4000 product registrations covering 36 therapeutic segments, the company has set up its presence in 23 countries. It specializes in producing and marketing of wide range of generic formulations and branded products and exporting them to markets like the US, European Union, Africa, LATAM and others. The company has also established a trading branch in Nairobi Kenya and a warehouse in Miami USA in collaboration with Lockett Corp. It completed splitting its shares in 2016 from Rs. 10 to Rs. 2 each. As on date, the company has three subsidiaries in India, Hong Kong and Colombia. It invested in Argus Salud Pharma LLP and set up a Joint venture in China. It also ventured into the ecommerce space. In the year 2021, the company has already received four ANDA approvals and 8 product launches. It has planned to file more 18 ANDAs with an addressable market size of USD 1.95 billion and is investing a sum of Rs. 140 crores in setting up its second Injectable Plant with 2 Vial lines, a Lyophilizer line and a Pre filled syringe line.

Share Price: ₹1845.65 per share as on 05 Mar, 2025 04:01 PM
Market Capitalisation: ₹13,757.74Cr as of today
Revenue: ₹492.96Cr as on December 2024 (Q4 24)
Net Profit: ₹140.07Cr as on December 2024 (Q4 24)
Listing date: 23 Jun, 2014
Chairperson Name: C C Paarthipan
OrganisationCaplin Point Laboratories Ltd
HeadquartersChennai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Caplin Point Laboratories Ltd

What is Caplin Point Laboratories Ltd price today?

Caplin Point Laboratories Ltd share price today stands at ₹1845.65, Open: ₹1800, Previous Close: ₹1809.95, High: ₹1867, Low: ₹1789.35, 52 Week High: ₹2641, 52 Week Low: ₹1225.

How to Buy Caplin Point Laboratories Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Caplin Point Laboratories Ltd shares

Is Caplin Point Laboratories Ltd listed on NSE?

Caplin Point Laboratories Ltd is listed on NSE

Is Caplin Point Laboratories Ltd listed on BSE?

Caplin Point Laboratories Ltd is listed on BSE

What are today's High and Low prices of Caplin Point Laboratories Ltd?

  • Today's highest price of Caplin Point Laboratories Ltd is ₹1867.
  • Today's lowest price of Caplin Point Laboratories Ltd is ₹1789.35.

What are today's traded volumes of Caplin Point Laboratories Ltd?

Today's traded volume of Caplin Point Laboratories Ltd(CAPLIPOINT) is 1.02L.

What is today's market capitalisation of Caplin Point Laboratories Ltd?

Today's market capitalisation of Caplin Point Laboratories Ltd(CAPLIPOINT) is ₹13757.74Cr.

What is the 52 Week High and Low Range of Caplin Point Laboratories Ltd?

Caplin Point Laboratories Ltd (CAPLIPOINT)
Price
52 Week High
₹2641
52 Week Low
₹1225

How much percentage Caplin Point Laboratories Ltd is down from its 52 Week High?

Caplin Point Laboratories Ltd (CAPLIPOINT) share price is ₹1845.65. It is down -30.12% from its 52 Week High price of ₹2641

How much percentage Caplin Point Laboratories Ltd is up from its 52 Week low?

Caplin Point Laboratories Ltd (CAPLIPOINT) share price is ₹1845.65. It is up 50.67% from its 52 Week Low price of ₹1225

What are the historical returns of Caplin Point Laboratories Ltd?

Caplin Point Laboratories Ltd (CAPLIPOINT)
Returns
1 Day Returns
35.7%
1 Month Returns
-17.69%
3 Month Returns
-23.97%
1 Year Returns
26.56%

What is the PE ratio of Caplin Point Laboratories Ltd today?

PE Ratio of Caplin Point Laboratories Ltd is 26.68

PE ratio = Caplin Point Laboratories Ltd Market price per share / Caplin Point Laboratories Ltd Earnings per share